Preventive therapy for nausea and vomiting in patients on opioid therapy for non malignant pain in rheumatology;Intérêt de la prévention des nausées et vomissements chez des patients traités par morphine pour des douleurs bénignes d'origine rhumatologique

Therapie

Volumn 57, Issue 5, 2002, Pages 446-449

  Scotto di Fazano, C ^a   Vergne, P ^a   Grilo, R M ^a   Bertin, P ^a   Bonnet, C ^a   Treves R ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

Nausea and vomiting; Non malignant pain; Opioids; Prevention

Indexed keywords

METOCLOPRAMIDE; MORPHINE SULFATE; MU OPIATE RECEPTOR;

ADULT; ANTIEMETIC ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPEN STUDY; PAIN; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RHEUMATIC DISEASE; TREATMENT OUTCOME; VOMITING;

AGED; ANALGESICS, OPIOID; ANTIEMETICS; FEMALE; HUMANS; MALE; METOCLOPRAMIDE; MIDDLE AGED; MORPHINE; NAUSEA; PAIN; RHEUMATIC DISEASES; VOMITING;

EID: 17444452840     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Perrot S. La morphine dans les douleurs articulaires non cancéreuses. Rev Rhum Ed Fr 1999; 66(5): 309-16
2. Perrot S, Bannwarth B, Bertin P, et al. Use of morphine in non malignant joint pain: the Limoges recommendations. Rev Rhum Engl Ed 1999; 66(11): 571-6
3. American Academy of Pain Medicine and American Pain Society: The use of opioids for the treatment of chronic pain. A consensus statement. Clin J Pain 1997; 13: 6-8
4. Pichard E, Poulain P. On the good use of opiates. Rev Prat 1985; 35(21): 1239-45
5. Chauvin M, Viars P. Morphiniques et antimorphiniques en anesthésiologie. In: Giroud JP, Mathé G, Meyniel G. Pharmacologie Clinique. Bases de la thérapeutique. Paris: Expansion Scientifique Française, 1988: 1018-20
6. Page, Curtis, Sutter. Physiopathologie et maladies du système nerveux central. Pharmacologie intégrée. Bibliothèque nationale de Paris 1999: 128-33
7. Blanquaert JP. Lefebvre RA. Willems JL. Emetic and antiemetic effects of opioids in the dog. Eur J Pharmacol 1986; 128: 143-50
8. Costello DJ, Borison HL. Naloxone antagonizes narcotic self-blockade of emesis in the cat. J Pharmac Exp Ther 1977; 203: 222-30
9. Mantovani G, Curreli L, Maccio A, et al. Prevention of nausea and vomiting in cancer patients receiving high-dose Cisplatin. Assessment of the potential antiemetic activity of transdermal Fentanyl compared to standard antiemetic treatment in acute and delayed nausea and vomiting: first clinical report. Anticancer Research 1999; 19: 3495-502
10. Andrews PLR, Bhandari P, Davis CJ. Plasticity and modulation of the emetic reflex. In: Mechanisms and control of emesis (Bianchi AL, Grélot L, Miller AD, King GL,eds). London, Libbey 1992: 275-84
11. Grunberg SM. Innovative approaches in the treatment of emesis. Support Care Cancer 1997; 5: 9-11
12. Tonini M. Recent advances in the pharmacology of gastrointestinal prokinetics. Pharmacol Res 1996; 33: 217-26
13. Herrstedt J. Antiemetic research: a look to the future. Support Care Cancer 1998; 6: 8-12
14. Pitkänen MT, Niemi L, Tuominen MK, et al. Effect of tropisetron, a 5-HT3 receptor antagonist, on analgesia and nausea after intrathecal morphine. Br J Anesth 1993; 71: 681-4